{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:52:09Z","timestamp":1790261529777,"version":"4.1.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007553","name":"Aids Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006282","name":"Koning Boudewijnstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02251","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T10:15:25Z","timestamp":1568974525000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":63,"title":["The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like"],"prefix":"10.3389","volume":"10","author":[{"given":"Gilles","family":"Darcis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Berkhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander O.","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/nm1295-1284","article-title":"In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency","volume":"1","author":"Chun","year":"1995","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/77481","article-title":"Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy","volume":"6","author":"Chun","year":"2000","journal-title":"Nat Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/imr.12065","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol Rev"},{"key":"B10","first-page":"128","article-title":"Immune activation, HIV persistence, and the cure","volume":"21","author":"Douek","year":"2013","journal-title":"Top Antivir Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0185761","DOI":"10.1371\/journal.pone.0185761","article-title":"Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium","volume":"12","author":"De Voeght","year":"2017","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.it.2016.12.003","article-title":"HIV latency: should we shock or lock?","volume":"38","author":"Darcis","year":"2017","journal-title":"Trends Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.chom.2016.08.011","article-title":"HIV reservoir: finding the right needles in a needlestack","volume":"20","author":"Pasternak","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.immuni.2012.08.010","article-title":"Redefining the viral reservoirs that prevent HIV-1 eradication","volume":"37","author":"Eisele","year":"2012","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tim.2015.01.013","article-title":"Towards an HIV-1 cure: measuring the latent reservoir","volume":"23","author":"Bruner","year":"2015","journal-title":"Trends Microbiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1073\/pnas.1609057113","article-title":"Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy","volume":"113","author":"Imamichi","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1172\/JCI120549","article-title":"HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers","volume":"128","author":"Sharaf","year":"2018","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12977-019-0481-2","article-title":"On the generation of the MSD-\u03a8 class of defective HIV proviruses","volume":"16","author":"Das","year":"2019","journal-title":"Retrovirology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/CMR.00015-16","article-title":"Total HIV-1 DNA, a marker of viral reservoir dynamics with clinical implications","volume":"29","author":"Avettand-Fenoel","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"B21","first-page":"172","article-title":"Disrupting T-cell homeostasis: how HIV-1 infection causes disease","volume":"5","author":"Douek","year":"2003","journal-title":"AIDS Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12977-018-0392-7","article-title":"Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs","volume":"15","author":"Baxter","year":"2018","journal-title":"Retrovirology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"a006916","DOI":"10.1101\/cshperspect.a006916","article-title":"Transcriptional and posttranscriptional regulation of HIV-1 gene expression","volume":"2","author":"Karn","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-981-13-0484-2_8","article-title":"The molecular biology of HIV latency","volume":"1075","author":"Khoury","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1742-4690-8-60","article-title":"Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function","volume":"8","author":"Kula","year":"2011","journal-title":"Retrovirology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e02158","DOI":"10.1128\/mBio.02158-18","article-title":"Posttranscriptional regulation of HIV-1 gene expression during replication and reactivation from latency by nuclear matrix protein MATR3","volume":"9","author":"Sarracino","year":"2018","journal-title":"MBio"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1128\/JVI.01913-15","article-title":"A subset of CD4\/CD8 double-negative T cells expresses HIV proteins in patients on antiretroviral therapy","volume":"90","author":"DeMaster","year":"2016","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.chom.2016.07.015","article-title":"Single-cell characterization of viral translation-competent reservoirs in HIV-infected individuals","volume":"20","author":"Baxter","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e00876","DOI":"10.1128\/mBio.00876-17","article-title":"A novel single-cell FISH-flow assay identifies effector memory CD4(+) T cells as a major niche for HIV-1 transcription in HIV-infected patients","volume":"8","author":"Grau-Exp\u00f3sito","year":"2017","journal-title":"MBio"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/infdis\/jis502","article-title":"Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma","volume":"206","author":"Pasternak","year":"2012","journal-title":"J Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e37792","DOI":"10.1371\/journal.pone.0037792","article-title":"Immune and viral correlates of secondary viral control after treatment interruption in chronically HIV-1 infected patients","volume":"7","author":"Van Gulck","year":"2012","journal-title":"PLoS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-4690-10-41","article-title":"Cell-associated HIV RNA: a dynamic biomarker of viral persistence","volume":"10","author":"Pasternak","year":"2013","journal-title":"Retrovirology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.virol.2010.12.041","article-title":"HIV reservoirs and latency models","volume":"411","author":"Pace","year":"2011","journal-title":"Virology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12977-018-0397-2","article-title":"What do we measure when we measure cell-associated HIV RNA","volume":"15","author":"Pasternak","year":"2018","journal-title":"Retrovirology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13148-016-0185-6","article-title":"Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals","volume":"8","author":"Trejbalova","year":"2016","journal-title":"Clin Epigenetics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41467-019-08431-7","article-title":"Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion","volume":"10","author":"Pinzone","year":"2019","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1172\/JCI124291","article-title":"Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy","volume":"129","author":"Einkauf","year":"2019","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1007357","DOI":"10.1371\/journal.ppat.1007357","article-title":"Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency","volume":"14","author":"Telwatte","year":"2018","journal-title":"PLoS Pathog"},{"key":"B39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/COH.0000000000000482","article-title":"Markers of the HIV-1 reservoir: facts and controversies","volume":"13","author":"Bruel","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"key":"B40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11904-017-0355-y","article-title":"The alphabet soup of HIV reservoir markers","volume":"14","author":"Sharaf","year":"2017","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.immuni.2018.02.010","article-title":"Understanding subset diversity in T cell memory","volume":"48","author":"Jameson","year":"2018","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/COH.0000000000000281","article-title":"Diversity of HIV-1 reservoirs in CD4+ T-cell subpopulations","volume":"11","author":"Lee","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1086\/656721","article-title":"Both CD31(+) and CD31\u2212 naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy","volume":"202","author":"Wightman","year":"2010","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1097\/QAD.0000000000001029","article-title":"Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy","volume":"30","author":"Khoury","year":"2016","journal-title":"AIDS"},{"key":"B46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nm.3445","article-title":"HIV-1 persistence in CD4+ T cells with stem cell-like properties","volume":"20","author":"Buzon","year":"2014","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz108.","article-title":"Naive CD4+ T cells harbor a large inducible reservoir of latent, replication-competent HIV-1","author":"Zerbato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz378.","article-title":"Genetic evidence that Na\u00efve T cells can contribute significantly to the HIV intact reservoir: time to re-evaluate their role","author":"Venanzi Rullo","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","article-title":"Identification of genetically intact HIV-1 proviruses in specific CD4(+) T cells from effectively treated participants","volume":"21","author":"Hiener","year":"2017","journal-title":"Cell Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clim.2015.04.010","article-title":"Polarization diversity of human CD4+ stem cell memory T cells","volume":"159","author":"Takeshita","year":"2015","journal-title":"Clin Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1172\/JCI93289","article-title":"Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells","volume":"127","author":"Lee","year":"2017","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/QAD.0000000000001309","article-title":"HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy","volume":"31","author":"Gosselin","year":"2017","journal-title":"AIDS"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1182\/blood-2012-09-378653","article-title":"Essentials of Th17 cell commitment and plasticity","volume":"121","author":"Muranski","year":"2013","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"11284","DOI":"10.1128\/JVI.01595-15","article-title":"Th1\/17 polarization of CD4 T cells supports HIV-1 persistence during antiretroviral therapy","volume":"89","author":"Sun","year":"2015","journal-title":"J Virol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11904-018-0378-z","article-title":"HIV persistence in adipose tissue reservoirs","volume":"15","author":"Couturier","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e00065","DOI":"10.1128\/JVI.00065-19","article-title":"Infectious virus persists in CD4+ T cells and macrophages in ART-suppressed SIV-infected Macaques","volume":"93","author":"Abreu","year":"2019","journal-title":"J Virol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13148-015-0137-6","article-title":"Epigenetic control of HIV-1 post integration latency: implications for therapy","volume":"7","author":"Kumar","year":"2015","journal-title":"Clin Epigenetics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1128\/JVI.00290-16","article-title":"Quantitation of productively infected monocytes and macrophages of simian immunodeficiency virus-infected macaques","volume":"90","author":"Avalos","year":"2016","journal-title":"J Virol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41564-018-0335-z","article-title":"HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy","volume":"4","author":"Ganor","year":"2019","journal-title":"Nat Microbiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1097\/QAD.0000000000001281","article-title":"Exploring the anatomical HIV reservoirs: role of the testicular tissue","volume":"30","author":"Darcis","year":"2016","journal-title":"AIDS"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1097\/QAD.0000000000001282","article-title":"Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults","volume":"30","author":"Jenabian","year":"2016","journal-title":"AIDS"},{"key":"B63","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/COH.0000000000000293","article-title":"Tissue reservoirs of HIV","volume":"11","author":"Wong","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3389\/fimmu.2019.01435","article-title":"The HIV reservoir in monocytes and macrophages","volume":"10","author":"Wong","year":"2019","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"12078","DOI":"10.1038\/s41598-019-48354-3","article-title":"A Tat\/Rev induced limiting dilution assay to measure viral reservoirs in non-human primate models of HIV infection","volume":"9","author":"Frank","year":"2019","journal-title":"Sci Rep"},{"key":"B66","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1093\/infdis\/jiw637","article-title":"In vivo models of human immunodeficiency virus persistence and cure strategies","volume":"215","author":"Nixon","year":"2017","journal-title":"J Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.it.2017.04.007","article-title":"Signature of the sleeper cell: a biomarker of HIV latency revealed","volume":"38","author":"Pillai","year":"2017","journal-title":"Trends Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-med-092112-152941","article-title":"Understanding HIV latency: the road to an HIV cure","volume":"66","author":"Dahabieh","year":"2015","journal-title":"Annu Rev Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1005349","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection","volume":"12","author":"Chew","year":"2016","journal-title":"PLoS Pathog"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1005761","DOI":"10.1371\/journal.ppat.1005761","article-title":"CD4+ T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART","volume":"12","author":"Fromentin","year":"2016","journal-title":"PLoS Pathog"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e1007619","DOI":"10.1371\/journal.ppat.1007619","article-title":"Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection","volume":"15","author":"Pardons","year":"2019","journal-title":"PLoS Pathog"},{"key":"B73","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41467-019-08798-7","article-title":"PD-1 blockade potentiates HIV latency reversal ex vivo in CD4(+) T cells from ART-suppressed individuals","volume":"10","author":"Fromentin","year":"2019","journal-title":"Nat Commun"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0211112","DOI":"10.1371\/journal.pone.0211112","article-title":"Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART","volume":"14","author":"Bui","year":"2019","journal-title":"PLoS ONE"},{"key":"B75","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1038\/ncomms9495","article-title":"Immunological biomarkers predict HIV-1 viral rebound after treatment interruption","volume":"6","author":"Hurst","year":"2015","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fimmu.2018.00144","article-title":"Blood CXCR3+ CD4 T cells are enriched in inducible replication competent HIV in aviremic antiretroviral therapy-treated individuals","volume":"9","author":"Banga","year":"2018","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20121932","article-title":"Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production","volume":"210","author":"Perreau","year":"2013","journal-title":"J Exp Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nm.3781","article-title":"B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers","volume":"21","author":"Fukazawa","year":"2015","journal-title":"Nat Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/QAI.0000000000002026","article-title":"Impact of Integrase Inhibition compared to non-nucleoside inhibition on HIV reservoirs in Lymphoid Tissues","volume":"81","author":"Rothenberger","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.4411","article-title":"Defining total-body AIDS-virus burden with implications for curative strategies","volume":"23","author":"Estes","year":"2017","journal-title":"Nat Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B83","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.immuni.2017.09.018","article-title":"CTLA-4+PD-1- Memory CD4+ T cells critically contribute to viral persistence in antiretroviral therapy-suppressed, SIV-infected rhesus macaques","volume":"47","author":"McGary","year":"2017","journal-title":"Immunity"},{"key":"B84","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1365-2567.2010.03255.x","article-title":"T-cell exhaustion: characteristics, causes and conversion","volume":"129","author":"Yi","year":"2010","journal-title":"Immunology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3389\/fimmu.2018.02339","article-title":"Targeting immune checkpoint molecules to eliminate latent HIV","volume":"9","author":"Boyer","year":"2018","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2019.03.004","article-title":"Between a shock and a hard place: challenges and developments in HIV latency reversal","volume":"38","author":"Zerbato","year":"2019","journal-title":"Curr Opin Virol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/annonc\/mdx696","article-title":"Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer","volume":"29","author":"Guihot","year":"2018","journal-title":"Ann Oncol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/annonc\/mdy259","article-title":"Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection","volume":"29","author":"Scully","year":"2018","journal-title":"Ann Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s40259-016-0204-3","article-title":"Immune-related adverse events associated with immune checkpoint inhibitors","volume":"30","author":"Day","year":"2016","journal-title":"BioDrugs"},{"key":"B90","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.4049\/jimmunol.181.11.7713","article-title":"An in vitro system to model the establishment and reactivation of HIV-1 latency","volume":"181","author":"Marini","year":"2008","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1128\/JVI.01297-13","article-title":"High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects","volume":"87","author":"Iglesias-Ussel","year":"2013","journal-title":"J Virol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/eji.200324344","article-title":"CD30 ligation differentially affects CXCR4-dependent HIV-1 replication and soluble CD30 secretion in non-Hodgkin cell lines and in gamma delta T lymphocytes","volume":"33","author":"Biswas","year":"2003","journal-title":"Eur J Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0165-2478(96)02559-X","article-title":"Role for CD30 in HIV expression","volume":"51","author":"Romagnani","year":"1996","journal-title":"Immunol Lett"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e1006856","DOI":"10.1371\/journal.ppat.1006856","article-title":"Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30","volume":"14","author":"Hogan","year":"2018","journal-title":"PLoS Pathog"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/bloodadvances.2018024364","article-title":"Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma","volume":"2","author":"Wang","year":"2018","journal-title":"Blood Adv"},{"key":"B96","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1038\/s41467-019-11556-4","article-title":"Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab","volume":"10","author":"Serra-Peinado","year":"2019","journal-title":"Nat Commun"},{"key":"B97","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrd2909","article-title":"Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond","volume":"11","author":"Hogarth","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.3389\/fimmu.2018.02814","article-title":"CD32 ligation promotes the activation of CD4+ T cells","volume":"9","author":"Holgado","year":"2018","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature21710","article-title":"CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses","volume":"543","author":"Descours","year":"2017","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","first-page":"eaar6759","DOI":"10.1126\/scitranslmed.aar6759","article-title":"CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells","volume":"10","author":"Abdel-Mohsen","year":"2018","journal-title":"Sci Transl Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3389\/fimmu.2018.00928","article-title":"CD32-expressing CD4 T cells are phenotypically diverse and can contain proviral HIV DNA","volume":"9","author":"Martin","year":"2018","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41467-018-05157-w","article-title":"CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir","volume":"9","author":"Badia","year":"2018","journal-title":"Nat Commun"},{"key":"B103","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1038\/s41586-018-0493-4","article-title":"Conflicting evidence for HIV enrichment in CD32","volume":"561","author":"P\u00e9rez","year":"2018","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1038\/s41586-018-0494-3","article-title":"The role of CD32 during HIV-1 infection","volume":"561","author":"Bertagnolli","year":"2018","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.1038\/s41586-018-0495-2","article-title":"Evidence that CD32a does not mark the HIV-1 latent reservoir","volume":"561","author":"Osuna","year":"2018","journal-title":"Nature"},{"key":"B106","article-title":"CD32+CD4+ T cells are enriched in HIV DNA","volume-title":"Conference on Retroviruses and Opportunistic Infections","author":"Darcis","year":"2019"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41385-019-0180-2","article-title":"CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype","volume":"12","author":"Thornhill","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e00901","DOI":"10.1128\/JVI.00901-18","article-title":"CD32(+) and PD-1(+) lymph node CD4 T cells support persistent HIV-1 transcription in treated aviremic individuals","volume":"92","author":"Noto","year":"2018","journal-title":"J Virol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/QAI.0000000000001622","article-title":"CD32 Expression of different memory T cell subpopulations in the blood and lymph nodal tissue of HIV patients and healthy controls correlates with immune activation","volume":"77","author":"Wittner","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e1004955","DOI":"10.1371\/journal.ppat.1004955","article-title":"HIV latency is established directly and early in both resting and activated primary CD4 T cells","volume":"11","author":"Chavez","year":"2015","journal-title":"PLoS Pathog"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e1003259","DOI":"10.1371\/journal.ppat.1003259","article-title":"Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes","volume":"9","author":"van der Sluis","year":"2013","journal-title":"PLoS Pathog"},{"key":"B112","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.1128\/JVI.00492-07","article-title":"Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4\/CD8 double-negative T lymphocytes","volume":"81","author":"Kaiser","year":"2007","journal-title":"J Virol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1172\/JCI26197","article-title":"HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir","volume":"115","author":"Chun","year":"2005","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","first-page":"147","DOI":"10.20411\/pai.v4i1.271","article-title":"CD32-RNA co-localizes with HIV-RNA in CD3+ cells found within gut tissues from viremic and ART-suppressed individuals","volume":"4","author":"V\u00e1squez","year":"2019","journal-title":"Pathog Immun"},{"key":"B115","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"Lorenzo-Redondo","year":"2016","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","first-page":"eaap8758","DOI":"10.1126\/scitranslmed.aap8758","article-title":"Heterogeneous antiretroviral drug distribution and HIV\/SHIV detection in the gut of three species","volume":"11","author":"Thompson","year":"2019","journal-title":"Sci Transl Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.192.5.637","article-title":"B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells","volume":"192","author":"Moir","year":"2000","journal-title":"J Exp Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1371\/journal.ppat.0020070","article-title":"DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes","volume":"2","author":"Rappocciolo","year":"2006","journal-title":"PLoS Pathog"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T10:15:29Z","timestamp":1568974529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":118,"alternative-id":["10.3389\/fimmu.2019.02251"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02251","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]},"article-number":"2251"}}